Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver transplantation 2022-05, Vol.28 (5), p.895-896
Hauptverfasser:	Yang, Zhe, Sun, Jingqi, Zhuang, Li, Mou, Haibo, Zheng, Shusen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized Bevacizumab Bevacizumab - therapeutic use Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Hepatocellular carcinoma Humans Immunotherapy Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - pathology Liver Neoplasms - surgery Liver transplantation Liver Transplantation - adverse effects Liver transplants Monoclonal antibodies Salvage Therapy Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!